Ignite Creation Date:
2024-05-06 @ 4:07 PM
Last Modification Date:
2024-10-26 @ 2:03 PM
Study NCT ID:
NCT04870346
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2023-08-07
First Post:
2021-04-22
Brief Title:
Long Term Follow-up Observational Study After Clinical Trials of AMG531 Romiplostim in Patients With Untreated Aplastic Anemia
Sponsor:
Kyowa Kirin Co Ltd
Organization:
Kyowa Kirin Co Ltd
Study Overview
Official Title:
Long Term Follow-up Observational Study After Clinical Trials of AMG531 Romiplostim in Patients With Untreated Aplastic Anemia
Status:
ACTIVE_NOT_RECRUITING
Status Verified Date:
2024-10
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
To evaluate the long-term efficacy and safety after the end of romiplostim treatment by observation up to 5 years of patients who were registered for Study 531-003531-004 in immunosuppressive therapy-naïve patients with aplastic anemia
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None